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Cardiac Time Intervals Measured by Tissue Doppler Imaging M-mode:
Association With Hypertension, Left Ventricular Geometry, and Future
Ischemic Cardiovascular Diseases
Tor Biering-Sørensen, MD, PhD; Rasmus Mogelvang, MD, PhD; Peter Schnohr, MD, DMSc; Jan Skov Jensen, MD, PhD, DMSc
Background-—We hypothesized that the cardiac time intervals reveal reduced myocardial function in persons with hypertension
and are strong predictors of future ischemic cardiovascular diseases in the general population.
Methods and Results-—In a large community-based population study, cardiac function was evaluated in 1915 participants by using
both conventional echocardiography and tissue Doppler imaging (TDI). The cardiac time intervals, including the isovolumic
relaxation time (IVRT), isovolumic contraction time (IVCT), and ejection time (ET), were obtained by TDI M-mode through the mitral
leaﬂet. IVCT/ET, IVRT/ET, and myocardial performance index [MPI=(IVRT+IVCT)/ET] were calculated. After multivariable
adjustment for clinical variables the IVRT, IVRT/ET, and MPI, remained signiﬁcantly impaired in persons with hypertension (n=826)
compared with participants without hypertension (n=1082). Additionally, they displayed a signiﬁcant dose–response relationship,
between increasing severity of elevated blood pressure and increasing left ventricular mass index (P<0.001 for all). Further, during
follow-up of a median of 10.7 years, 435 had an ischemic cardiovascular disease (ischemic heart disease, peripheral arterial
disease, or stroke). The IVRT/ET and MPI were powerful and independent predictors of future cardiovascular disease, especially in
participants with known hypertension. They provide prognostic information incremental to clinical variables from the Framingham
Risk Score, the SCORE risk chart, and the European Society of Hypertension/European Society of Cardiology risk chart.
Conclusion-—The cardiac time intervals identify impaired cardiac function in individuals with hypertension, not only independent of
conventional risk factors but also in participants with a normal conventional echocardiographic examination. The IVRT/ET and MPI
are independent predictors of future cardiovascular disease especially in participants with known hypertension. ( J Am Heart
Assoc. 2016;5:e002687 doi: 10.1161/JAHA.115.002687)
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H ypertension is common in the general population; theprevalence is reported to be 30% to 45%.1 Increasing
blood pressure (BP) and hypertension are strong predictors
of future ischemic cardiovascular diseases (ICVDs) such as
stroke, ischemic heart disease (IHD), and peripheral artery
disease (PAD).2–4 The risk of ICVD increases continuously
with increasing BP without any evidence of a lower
threshold.5 In addition, the presence of elevated BP leads
to organ damage in the heart, eyes, blood vessels, kidneys,
and brain, all of which often is asymptomatic.1 Asymp-
tomatic organ damage is an intermediate in the continuum
from elevated BP to fulminant ICVD. When asymptomatic
organ damage of the heart has occurred, the progression to
fulminant ICVD is imminent, explaining the increased risk of
ICVD with the observation of asymptomatic organ dam-
age.1,6–8 Increased BP and hypertension leads to speciﬁc
changes in the heart characterized by left ventricular (LV)
hypertrophy (LVH) and diastolic dysfunction.1,9,10 Including
echocardiography in the risk stratiﬁcation of patients with
hypertension has been demonstrated to be valuable6,11,12;
however, echocardiography is not recommended as a part of
the ﬁrst line of the diagnostic workup in patients with
hypertension.1 Nevertheless, because the risk of ICVD
increases continuously with increasing BP5 and LVH,7,8 the
optimal echocardiographic marker for risk stratiﬁcation in
hypertension-related diseases should be able to display
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changes in both severity of elevated BP and LV geometry,
improve the current risk prediction models, and identify early
cardiac impairment before the development of asymptomatic
organ damage of the heart.
The cardiac time intervals are sensitive markers of cardiac
dysfunction, even when it goes unrecognized by conventional
echocardiography,13–15 and they have previously been
demonstrated to contain prognostic information incremental
to the conventional echocardiographic parameters in various
populations.16–19 A novel method of obtaining the global
cardiac time intervals has recently evolved. With use of this
method, the cardiac time intervals are obtained by evaluating
the mitral valve movement through the cardiac cycle with
simple color TDI M-mode analysis.19–22
However, it is unknown if the cardiac time intervals are
able to identify miniscule cardiac impairments in individuals
with hypertension, which are unrecognized by conventional
echocardiography, and if these time intervals are affected
according to BP severity and LV geometry. Further, it is
unknown if these cardiac time intervals can be used to predict
hypertension-related diseases such as ICVDs.
Methods
Study Population
Within the Copenhagen City Heart Study, a longitudinal cohort
study of cardiovascular disease and risk factors, an echocar-
diographic substudy was performed.22–25 The present study
includes all participants from the fourth Copenhagen City
Heart Study examination 2001–2003 who had an echocar-
diographic examination, including TDI, performed (Figure 1).
We hereby obtained cardiac time intervals from 1915
participants aged 20 to 93 years. Participants in whom time
intervals were unmeasurable were caused by the trigger point
not being placed at the QRS complex or the TDI image not
including the whole cardiac cycle. The present study only
included participants in whom all the cardiac time intervals
were measurable. Whether a participant underwent echocar-
diography as part of the fourth Copenhagen City Heart Study
examination was independent of his or her health status and
other risk factors (Figure 1).
All participants gave written informed consent, and the
study was performed in accordance with the second
Helsinki Declaration and approved by the regional ethics
committee.
Health Examination
All participants answered a self-administered questionnaire
and underwent thorough physical examinations. BP of all
participants was measured with the London School of Hygiene
sphygmomanometer. Hypertension was deﬁned as systolic BP
(SBP) of ≥140 mm Hg, diastolic BP (DBP) of ≥90 mm Hg, or
use of antihypertensive medication.26 A 12-lead ECG was
recorded at rest in a supine position and coded according to
the Minnesota code. Plasma cholesterol and blood glucose
values were measured on nonfasting venous blood samples.27
Diabetes mellitus was deﬁned as plasma glucose concentra-
tion of ≥11.1 mmol/L, use of insulin or other antidiabetic
medicine, self-reported disease, or hemoglobin A1c level of
≥7.0%.28,29 Previous IHD was deﬁned as a history of hospital
admission for acute coronary artery occlusion, percutaneous
coronary intervention or coronary artery bypass graft surgery,
or major ischemic alterations on the ECG as deﬁned by
Minnesota codes 1.1 to 3.
Figure 1. Flow diagram of the study population. TDI indicates
tissue Doppler imaging.
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Echocardiography
All echocardiograms were obtained by 3 sonographers with
the use of Vivid 5 ultrasound systems (GE Healthcare) with a
2.5-MHz transducer. All participants were examined with
conventional 2-dimensional echocardiography and color TDI.
All echocardiograms were stored on magneto-optical discs
and an external FireWire hard drive and analyzed ofﬂine with
commercially available software (EchoPac; GE Medical) by 2
investigators (T.B.S. and R.M.), who were blinded to all other
information.
Conventional echocardiography
Regional function was evaluated by the 16 standard segments
model, as suggested by the American Society of Echocardio-
graphy.9 LV ejection fraction (LVEF) was evaluated by 1
observer on the basis of the wall motion index score.30 LV
systolic dysfunction was deﬁned as LVEF <50%.23–25
An M-mode still frame between the tips of the mitral leaﬂets
and the tips of the papillary muscles was recorded in the
parasternal long-axis view. If the correct 90° angle to the long
axis of the ventricle could not be obtained, 2-dimensional
images were used instead to quantify the myocardial thickness
and the dimensions of the LV in end diastole (LVIDd) and the
left atrium in end-systole (LAd). LV mass index (LVMI) was
calculated as the anatomic mass9 divided by body surface
area.31 Pulsed-wave Doppler at the apical view was used to
record mitral inﬂow between the tips of the mitral leaﬂets. Peak
velocity of early (E) and atrial (A) diastolic ﬁlling and deceler-
ation time of the E-wave were measured, and the E/A ratio was
calculated. LV hypertrophy (LVH) was deﬁned as LVMI ≥96 g/
m2 for women and ≥116 g/m2 for men.9 LV dilatation was
considered present if LVIDd/height ≥3.3 cm/m.9
Diastolic dysfunction was deﬁned as deceleration time
<140 ms and E/A<50 years >2.5, E/A50–70 years >2, or E/
A>70 years >1.5.
25
Participants were stratiﬁed according to LV geometry.
Normal geometry was deﬁned as a relative wall thickness
(RWT) ≤0.42 and absence of LVH; concentric remodeling was
deﬁned as an RWT >0.42 and absence of LVH; eccentric
hypertrophy was deﬁned as an RWT ≤0.42 and the presence
of LVH; and concentric hypertrophy was deﬁned as an RWT
>0.42 and the presence of LVH.9
A normal conventional echocardiographic examination was
deﬁned as the absence of LVH, dilatation, LVEF <50%, and
diastolic dysfunction.25
Tissue Doppler imaging
Color TDI tracings were obtained with the range gate placed
at the septal and lateral mitral annulus in the 4-chamber view.
Figure 2. The cardiac time intervals assessed by a color tissue Doppler imaging (TDI) M-mode line
through the mitral leaﬂet. Left: Four-chamber gray-scale (bottom) and color TDI (top) views in end systole
displaying the position of the M-mode line used for measuring the cardiac time intervals. Right: Color
diagram of the TDI M-mode line through the mitral leaﬂet. AVC indicates aortic valve closure; AVO, aortic
valve opening; MV, mitral valve; MVC, MV closing; MVO, MV opening.
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The peak longitudinal early diastolic (e’) velocity was
measured, and the average was calculated from the lateral
and septal velocities and used to obtain the E/e’.
With placement of a 2- to 4-cm straight M-mode line
through the septal half of the mitral leaﬂet in the color TDI 4-
chamber view, the cardiac time intervals were measured
directly from the color diagram19,22 (Figure 2). The IVCT was
deﬁned as the time interval from the mitral valve closure,
determined by the color shift from blue/turquoise to red at
end diastole, to the aortic valve opening determined by the
color shift from blue to red (Figure 2). The ET was deﬁned as
the time interval from aortic valve opening to aortic valve
closing, determined by the color shift from red to blue at end
systole (Figure 2). The IVRT was deﬁned as the time interval
from the aortic valve closing to the mitral valve opening,
determined by the color shift from red-orange to yellow
(Figure 2). The method has previously been validated19,21,22
and demonstrated to be superior to the conventional method
of obtaining the cardiac time intervals.21,22 Further, we have
previously demonstrated high reproducibility of the method in
this population.22 Both isovolumic time intervals were divided
by ET, creating IVRT/ET and IVCT/ET, respectively, and MPI
was calculated as the sum of the 2 [(IVRT+IVCT)/ET].
Follow-up and Outcome
The primary end point of ICVD was the combined end point of
being admitted with IHD, PAD, or stroke. Follow-up was 100%.
Follow-up data on admission with IHD, PAD, or stroke were
obtained from the Danish National Board of Health’s National
Patient Registry, with the use of International Classiﬁcation of
Diseases, 10th Edition codes DG45 to DG459, DI20 to DI259,
DI608 to DI749, I213 to I258, and I613 to I713.
Statistics
Proportions were compared by using v2 test, continuous
Gaussian distributed variables with Student t test and Mann–
Whitney test if non–Gaussian distributed. The association
between the cardiac time intervals and hypertension was
tested by univariable and multivariable regression analyses
including signiﬁcant confounders detected from the baseline
differences between participants with and those without
hypertension (Table). Participants with missing data in either
of the variables included in multivariable models were
excluded from the analysis. Imputing of missing data was
not performed in the present report. Linearity, variance
homogeneity, and the assumption of normality were tested
with plots of residuals. Trends were analyzed by linear
regression analyses, and departure from linearity was
assessed by simultaneous assessment of linear and quad-
ratic effects. Cumulative incidence curves of future major
adverse cardiac events were obtained by competing risk Cox
proportional hazards regression models. Subdistribution
hazard ratios (SHRs) were calculated by competing risk
Cox proportional hazards regression analyses. The assump-
tions of proportional hazards in the models were tested
graphically and tested based on the Schoenfeld residuals.
Table. Population Characteristics
Nonhypertensive
(n=1082)
Hypertension
(n=826) P Value
Age, y 5115 6811 <0.001
Male sex, n 44% (473) 41% (337) 0.20
Systolic blood pressure,
mm Hg
12012 15618 <0.001
Diastolic blood pressure,
mm Hg
739 8512 <0.001
Heart rate, beats per
minute
6511 7012 <0.001
Smoking status
Never, n 35% (372) 32% (261)
Previous, n 31% (339) 36% (296) 0.10
Current, n 34% (366) 32% (261)
Diabetes, n 7% (75) 15% (124) <0.001
Cholesterol, mmol/L 5.31.1 5.81.1 <0.001
Previous ischemic heart
disease, n
3% (30) 10% (80) <0.001
Previous ischemic
stroke, n
1% (6) 4% (29) <0.001
BMI, kg/m2 24.53.4 26.64.2 <0.001
eGFR, mL/min per
1.73 m2
79.215.7 72.416.1 <0.001
Atrial fibrillation/flutter, n 1% (12) 3% (23) 0.007
LVEF <50%, n 1% (5) 2% (13) 0.012
LV dilatation, n 4% (38) 6% (41) 0.037
LV hypertrophy, n 9% (85) 29% (194) <0.001
LV diastolic dysfunction,
n
1% (5) 2% (15) 0.003
No. of ICVD events
during follow-up
13% (136) 36% (297) <0.001
Cardiac time intervals
IVRT, ms 9421 11024 <0.001
IVCT, ms 3613 3915 <0.001
ET, ms 28624 28130 <0.001
IVRT/ET 0.330.08 0.400.11 <0.001
IVCT/ET 0.130.05 0.140.06 <0.001
MPI 0.460.11 0.540.15 <0.001
BMI indicates body mass index; eGFR, estimated glomerular ﬁltration rate; ET, ejection
time; IVCT, isovolumic contraction time; IVRT, isovolumic relaxation time; LV, left
ventricle; LVEF, left ventricular ejection fraction; MPI, myocardial performance index.
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Models were constructed that used logistic regression
models and predicted the risk of future hypertension-related
ICVDs for participants followed for a median of 10.7 years.
Reclassiﬁcation analyses that used risk categories of 0% to
5%, 5% to 10%, 10% to 20%, and >20% for low-, intermediate-,
high-, and very high-risk categories,1 respectively, in accor-
dance with the Framingham Risk Score categories,32 were
used to assess the net reclassiﬁcation improvement33 when
adding the IVRT/ET, the MPI, LVEF, and diastolic dysfunction
to the signiﬁcant clinical predictors from the Framingham
Risk Score,32 the Systemic Coronary Evaluation (SCORE)
risk chart,34 and the European Society of Hypertension/
European Society of Cardiology (ESH/ESC) risk chart.1
Non–Gaussian distributed continuous variables (LVMI and
E/e’) were categorized into quartiles when included as
confounders in the models. A P-value ≤0.05 in 2-sided test
was considered statistically signiﬁcant. All analyses were
performed with STATA Statistics/Data analysis, SE 12.0
(StataCorp).
Results
Cardiac Time Intervals and Hypertension
Participants with hypertension displayed impaired systolic and
diastolic function as determined by affected systolic and
diastolic cardiac time intervals (Table). After multivariable
adjustment for clinical variables, the IVRT, the IVCT, and the
combined indexes including information about systolic and
diastolic function, the IVRT/ET, and the MPI, remained
independently impaired in participants with hypertension
(Figure 3). However, the IVCT did not remain signiﬁcantly
impaired in participants with hypertension when the analysis
was conﬁned to persons with a normal conventional echocar-
diographic examination (Figure 3). In contrast, the IVRT,
IVRT/ET, and MPI remained signiﬁcantly impaired after
multivariable adjustment when the analysis was conﬁned to
persons with a normal conventional echocardiographic exam-
ination (Figure 3).
Cardiac Time Intervals and Elevated BP
To investigate if cardiac dysfunction as assessed by cardiac
time intervals was associated to severity of elevated BP, our
study population was stratiﬁed into 4 groups according to BP:
normal, high normal, hypertension stage 1, and hypertension
stage 2 (Figure 4). The IVRT and the combined indexes,
including information about systolic and diastolic function, the
IVRT/ET, and the MPI, increased incrementally with increasing
severity of elevated BP (Figure 4). This pattern of incremental
increase with increasing severity of elevated BP remained
statistically signiﬁcant after multivariable adjustment for both
clinical variables and conventional echocardiographic param-
eters (Figure 4). The same incremental pattern was found
when stratifying the participants according to the tertiles of
the mean arterial BP (Figure 5). To determine if the cardiac
time intervals can detect miniscule cardiac dysfunction
preceding fulminant hypertension, we conﬁned the analysis
to participants without hypertension and found that the IVRT,
IVRT/ET, and MPI were signiﬁcantly higher in participants with
high-normal BP than in the group with normal BP (normal
versus prehypertensive: IVRT, 88 ms [95% CI 87–90 ms]
versus 98 ms [95% CI 97–100 ms], P<0.001; IVRT/ET, 0.31
[95% CI 0.30–0.31] versus 0.35 [95% CI 0.34–0.36], P<0.001;
MPI, 0.43 [95% CI 0.42–0.44] versus 0.48 [95% CI 0.47–
0.49], P<0.001).
Cardiac Time Intervals and LV Geometry
All the cardiac time intervals displayed impaired cardiac
function with increasing values of the IVRT, IVCT, IVRT/ET,
IVCT/ET, and MPI (b-coefﬁcients: IVRT, 2.15 ms; IVCT,
1.23 ms; IVRT/ET, 0.01; IVCT/ET, 0.01; MPI, 0.02) and
decreasing value of the ET (b-coefﬁcient: ET, 1.68) for
increasing LVMI (per. 10 g/m2 increase) (P<0.001 for all)
(Figure 5). This pattern remained statistically signiﬁcant for all
the cardiac time intervals even after multivariable adjustment
for age, sex, body mass index, estimated glomerular ﬁltration
rate, heart rate, SBP, DBP, diabetes, cholesterol, atrial
ﬁbrillation, IHD, ischemic stroke, LVEF <50%, LVIDd, LAd,
deceleration time, E/A ratio <1, and E/e’ (P<0.05 for all). All
the cardiac time intervals, except IVCT, displayed the same
pattern with increasing values of the IVRT, IVRT/ET, IVCT/ET,
and MPI (b-coefﬁcients: IVRT, 5.743 ms; IVRT/ET, 0.025;
IVCT/ET, 0.004; MPI, 0.029) and decreasing value of the ET
(b-coefﬁcient: ET, 3.733 ms) for increasing RWT (pr. 10%
increase) (P<0.02 for all). This pattern also remained statis-
tically signiﬁcant for all the cardiac time intervals, except for
the IVRT, after multivariable adjustment for the same variables
as listed earlier (P<0.05 for all).
Participants were divided into 4 groups according to their
LV geometry (Figure 6). Only the IVRT, IVRT/ET, and MPI
displayed impaired cardiac function in all the pathological LV
geometry groups (concentric remodeling, concentric hyper-
trophy, and eccentric hypertrophy) compared with partici-
pants with normal geometry (P<0.001 for all) (Figure 6). After
multivariable adjustment for age, sex, body mass index,
estimated glomerular ﬁltration rate, heart rate, hypertension,
SBP, DBP, diabetes, cholesterol, atrial ﬁbrillation, IHD,
ischemic stroke, LVEF <50%, LVIDd, LAd, deceleration time,
E/A ratio <1, and E/e’, only the combined indexes including
information about systolic and diastolic function, the IVRT/ET,
and the MPI, remained statistically signiﬁcantly impaired in all
the pathological LV geometry groups (Figure 6).
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Usefulness of the Cardiac Time Intervals to
Predict ICVDs
During follow-up of median 10.7 (IQR 7.3–11.1) years, 435
participants reached the combined end point of ICVD (IHD,
stroke, or PAD). In univariable analysis, all the cardiac time
intervals were signiﬁcant predictors of future ICVDs (P<0.001)
(Table S1 and Figures 7 and 8A). After multivariable adjust-
ment for age, sex, body mass index, estimated glomerular
ﬁltration rate, heart rate, hypertension, SBP, DBP, diabetes,
cholesterol, smoking status, atrial ﬁbrillation, IHD, ischemic
stroke, LVEF <50%, diastolic dysfunction, and LVH, only the
combined indexes including information about systolic and
diastolic function, the IVRT/ET, and the MPI remained
Figure 3. Systolic and diastolic function determined by the cardiac time intervals in participants with and without hypertension after
multivariable adjustment. Multivariable adjusted means are depicted for the cardiac time intervals in participants with and without hypertension
for both the entire study cohort and the subgroup with a normal conventional echocardiographic examination. Multivariable adjustment
designates adjustment for age, sex, body mass index, estimated glomerular ﬁltration rate, heart rate, diabetes, cholesterol, atrial ﬁbrillation,
ischemic heart disease and previous ischemic stroke. Normal echo designates the absence of left ventricular hypertrophy, dilatation and
ejection fraction <50%, and severe diastolic dysfunction.25 Bars indicate SE. ET indicates ejection time; IVCT, isovolumic contraction time; IVRT,
isovolumic relaxation time; MPI, myocardial performance index.
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independent predictors of future ICVDs (IVRT/ET: SHR, 1.11
[95% CI 1.00–1.23] per 0.1 increase, P=0.050; MPI: SHR,
1.11 [95% CI1.01–1.21] per 0.1 increase, P=0.024) (Fig-
ure 8C). When conﬁning the analysis to only include partic-
ipants with no previous history of IHD, IVRT/ET only remained
borderline signiﬁcant, whereas MPI remained an independent
predictor of ICVDs (IVRT/ET: SHR, 1.10 [95% CI 0.99–1.22]
per 0.1 increase, P=0.084; MPI: SHR, 1.10 [95% CI 1.00–
1.21] per 0.1 increase, P=0.047). Hypertension signiﬁcantly
modiﬁed the relationship between IVRT, IVRT/ET, MPI, and
ICVD (P for interaction: P≤0.001 for all). The IVRT, IVRT/ET,
and MPI primarily predicted ICVD in participants with
hypertension but not in participants without hypertension
(Figure 8D). Further, only the MPI remained an independent
predictor of ICVD in participants with hypertension (MPI: SHR,
1.12 [95% CI 1.01–1.23] per 0.1 increase, P=0.027) (Fig-
ure 8D). In addition, reclassiﬁcation analysis demonstrated
that adding IVRT/ET or MPI to the clinical predictors from the
Framingham Risk Score32 and the SCORE risk chart34 (age,
sex, cholesterol, smoking status, and SBP) yielded better
predicting models with signiﬁcant increase in the categorical
net reclassiﬁcation improvement of 0.0227 (95% CI 0.0017–
0.0437, P=0.034) for IVRT/ET and 0.402 (95% CI 0.0150–
0.0653, P=0.002) for the MPI, respectively. Additionally,
reclassiﬁcation analysis demonstrated that adding IVRT/ET or
MPI to a model including the clinical predictors from the
newer ESH/ESC risk chart1 (age, sex, smoking status,
cholesterol, diabetes, SBP, DBP, LVH, chronic kidney disease
[deﬁned as estimated glomerular ﬁltration rate ≤60 mL/min
per 1.73 m2], IHD, and ischemic stroke) yielded better
predicting models with signiﬁcant increase in the categorical
net reclassiﬁcation improvement of 0.0341 (95% CI 0.0079–
0.0603, P=0.011) for IVRT/ET and 0.344 (95% CI 0.0039–
0.0648, P=0.027) for the MPI, respectively. In contrast, when
Figure 4. Systolic and diastolic function determined by the cardiac time intervals according to elevated blood pressure severity. Depicting the
adjusted means of the cardiac time intervals in participants stratiﬁed according to blood pressure, after adjustment for age and sex. The study
population was divided into 4 groups according to blood pressure: normal (<120/80 mm Hg), high normal (between 120/80 and 140/
90 mm Hg), stage 1 hypertension (between 140/90 and 160/100 mm Hg), and stage 2 hypertension (≥160/100 mm Hg). The pattern of
incremental increase of the IVRT, IVRT/ET, and MPI with increasing severity of elevated blood pressure, remained statistically signiﬁcant after
multivariable adjustment for age, sex, body mass index, estimated glomerular ﬁltration rate, heart rate, diabetes, cholesterol, atrial ﬁbrillation,
ischemic heart disease, ischemich stroke, left ventricular ejection fraction <50%, left ventricular dimension in end diastole, left atrium diameter
in end systole, left ventricular mass index, deceleration time of early diastolic inﬂow, peak transmitral early diastolic inﬂow velocity/peak
transmitral late diastolic inﬂow velocity ratio <1, and E/e’. Bars indicate SE. ET indicates ejection time; IVCT, isovolumic contraction time; IVRT,
isovolumic relaxation time; MPI, myocardial performance index.
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adding LVEF or diastolic dysfunction to either of the
aforementioned models, the predicting models did not
improve. When added to the clinical predictors from the
Framingham Risk Score32 and the SCORE risk chart,34 P for
LVEF=0.62 and P for diastolic dysfunction=0.82; when added
to the clinical predictors from the newer ESH/ESC risk chart,1
P for LVEF=0.90 and P for diastolic dysfunction=0.12.
Discussion
In the largest prospective study to date of a random sample of
participants from the general population undergoing compre-
hensive echocardiography including an assessment of the
cardiac time intervals by TDI M-mode, we found that (1) the
cardiac time intervals (IVRT, IVRT/ET, and MPI) display
Figure 5. The association between the cardiac time intervals and LVMI and MAP. The association
between the cardiac time intervals and the LVMI and MAP. Participants were stratiﬁed into tertiles of the
LVMI and MAP. Bars indicate SE. ET indicates ejection time; IVRT, isovolumic relaxation time; LVMI, left
ventricular mass index; MAP, mean arterial blood pressure; MPI, myocardial performance index.
DOI: 10.1161/JAHA.115.002687 Journal of the American Heart Association 8
Cardiac Time Intervals and Hypertension Biering-Sørensen et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 by guest on January 26, 2018
http://jaha.ahajournals.org/
D
ow
nloaded from
 
impaired cardiac function in individuals with hypertension, not
only independent of conventional risk factors but also in
participants with a normal conventional echocardiographic
examination; (2) a signiﬁcant dose–response relationship
exists between increasing severity of BP and incremental
impairment in cardiac function determined by the cardiac time
intervals (IVRT, IVRT/ET, and MPI); (3) the combined indexes
encompassing information on both systolic and diastolic
function (the IVRT/ET and the MPI) independently display
cardiac dysfunction in all types of pathological LV geometry;
(4) the IVRT/ET and the MPI are independent predictors of
future ICVDs, even after adjustment for conventional echocar-
diographic parameters, but they primarily provide prognostic
information regarding the risk of future ICVD in participants
with hypertension; and (5) the IVRT/ET and the MPI improve
the predictive models for future ICVDs when added to the
Framingham Risk Score, the SCORE risk chart, and the ESH/
ESC risk chart.
Cardiac Time Intervals, Hypertension, and LV
Geometry
Cardiac function was signiﬁcantly impaired in participants
with hypertension compared with participants with normal
Figure 6. The cardiac time intervals in participants with normal left ventricular geometry (n=1122), concentric remodeling (n=259), eccentric
hypertrophy (n=177), and concentric hypertrophy (n=103). Cardiac time intervals are depicted in participants with normal left ventricular
geometry and pathological left ventricular geometry. Displays mean and SEs. *Signiﬁcant difference (P<0.01) when comparing the participants
with normal left ventricular geometry to participants with pathological left ventricular geometry. †P≤0.01 and ‡P≤0.05 after adjustment for age,
sex, body mass index, estimated glomerular ﬁltration rate, heart rate, hypertension, systolic and diastolic blood pressures, diabetes, cholesterol,
atrial ﬁbrillation, ischemic heart disease, previous ischemic stroke, left ventricular ejection fraction <50%, left ventricular dimension in end
diastole, left atrial diameter, deceleration time of early diastolic inﬂow, peak transmitral early diastolic inﬂow velocity/peak transmitral late
diastolic inﬂow velocity ratio <1, and E/e’, when comparing the participants with normal left ventricular geometry to participants with
pathological left ventricular geometry. ET indicates ejection time; IVCT, isovolumic contraction time; IVRT, isovolumic relaxation time; MPI,
myocardial performance index.
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BP, determined by affected systolic and diastolic cardiac
time intervals (Table). However, after multivariable adjust-
ment, and when conﬁning the analysis to participants with
a normal conventional echocardiographic examination,
only IVRT, IVRT/ET, and MPI remained signiﬁcantly impaired
in participants with hypertension (Figure 3). These results
were expected, because it is well known that patients
with hypertension primarily have an impaired diastolic
function and not an impaired systolic function,35,36 which
is in accordance with our results where only the time
intervals containing information about the diastolic function
remained impaired after multivariable adjustment.
However, the pivotal ﬁnding in Figure 3 was that the
cardiac time intervals were capable of identifying subtle
impairments in the cardiac function in participants with
hypertension, which were unnoticed with the use of
conventional echocardiography (Figure 3). Therefore, the
cardiac time intervals, containing information about dias-
tolic function, seem capable of identifying participants at
risk of hypertension-related asymptomatic organ damage
of the heart, despite of normal conventional echocardiog-
raphy.
In accord with our results, a previous small-scale study
with 62 hypertensive patients and 15 controls also found IVRT
Figure 7. The cardiac time intervals and risk of future ischemic cardiovascular disease. Depicting the
cumulative incidence of ICVD for participants stratiﬁed according to the tertiles of IVCT (1. tertile <30 ms;
2. tertile ≥30 ms to <40 ms; 3. tertile ≥40 ms), IVRT (1. tertile <90 ms; 2. tertile ≥90 ms to <109 ms; 3.
tertile ≥109 ms), ET (1. tertile <275 ms; 2. tertile ≥275 ms to <296 ms; 3. tertile ≥296 ms), IVCT/ET (1.
tertile <0.10; 2. tertile ≥0.10–<0.14; 3. tertile ≥0.14), IVRT/ET (1. tertile <0.31; 2. tertile ≥0.31–<0.39; 3.
tertile ≥0.39) and MPI (1. tertile <0.43; 2. tertile ≥0.43–<0.52; 3. tertile ≥0.52). ET indicates ejection time;
IVCT, isovolumic contraction time; IVRT, isovolumic relaxation time; MPI, myocardial performance index.
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and MPI to be the only cardiac time intervals demonstrating
impaired cardiac function in patients with hypertension,
despite a normal systolic function.37 Unfortunately, Caccia-
puoti and colleagues did not evaluate the diagnostic utility of
IVRT/ET in their study37; if they had, it would most likely also
be impaired in the hypertensive group.
We found a signiﬁcant linear dose–response relationship,
between increasing severity of elevated BP and incremental
impairment in cardiac function determined by the age- and
sex-adjusted cardiac time intervals (IVRT, IVRT/ET, and MPI)
(Figure 4). Even after multivariable adjustment for all other
clinical and conventional echocardiographic parameters, this
pattern of incremental increase in cardiac dysfunction deter-
mined by IVRT, IVRT/ET, and MPI, with increasing severity of
elevated BP, remained statistically signiﬁcant.
Likewise, a previous study demonstrated that MPI
increased with increasing severity of hypertension according
to LV geometry.38 Accordingly, we found that all the cardiac
time intervals displayed impaired cardiac function with
increasing values of the LVMI (Figure 5) even after multivari-
able adjustment. In addition, the IVRT/ET and the MPI
displayed cardiac dysfunction after multivariable adjustment
in all pathological LV geometry groups (Figure 6). These
ﬁndings of incremental impairment of the cardiac time
intervals (especially the IVRT/ET and MPI) with increasing
BP and LVMI (Figure 5), and in all types of pathological LV
geometry, are important, because a potential future echocar-
diographic parameter for risk stratiﬁcation in hypertension
should display incremental impairment in the measure with
increasing BP and LVMI and in all types of pathological LV
A B
C D
Figure 8. The cardiac time intervals as predictors of future ischemic cardiovascular disease (ICVD). Depicting the subdistribution hazard ratios
(SHRs) obtained from univariable analysis (A), adjusted for age, sex, systolic and diastolic blood pressures (B), and multivariable (C) competing
risk Cox proportional hazards regression models describing the cardiac time intervals as predictors of future hypertension-related ICVDs. The
IVRT, IVRT/ET, and MPI are also stratiﬁed according to hypertension status (D). Multivariable adjustment indicates adjustment for age, sex, body
mass index, estimated glomerular ﬁltration rate, heart rate, hypertension, systolic blood pressure, diastolic blood pressure, diabetes, cholesterol,
smoking status, atrial ﬁbrillation, ischemic heart disease, previous ischemic stroke, left ventricular ejection frasction <50%, diastolic dysfunction,
and left ventricular hypertrophy. Depicts the SHRs and the 95% CIs. ET indicates ejection time; IVCT, isovolumic contraction time; IVRT,
isovolumic relaxation time; MPI, myocardial performance index.
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geometry, as the risk of ICVD increases continuously with
increasing BP5 and LVH.7,8
In addition, another central observation in our study was that
IVRT and MPI were capable in detecting miniscule cardiac
dysfunction in participants with high-normal BP compared with
participants with normal BP, when conﬁning our analysis to
participants without hypertension and after adjustment for
clinical variables. This is important because it has previously
been demonstrated that persons with high-normal BP have an
increased risk of developing future hypertension39 and an
increased risk of ICVD.40 Thus, IVRT and MPI reveal impaired
cardiac function in persons with high-normal BP. Therefore
these time intervals may aid in the early identiﬁcation of
persons in high risk of future fulminant hypertension and ICVDs.
Cardiac Time Intervals and the Risk for ICVD
It is well known that hypertension is associated with
increased risk of ICVD3; however, the usefulness of the
cardiac time intervals to predict future ICVDs in the general
population and in participants with hypertension is unknown.
We found that only the combined indexes containing
information on both systolic and diastolic performance
(IVRT/ET and MPI) were independent predictors of future
ICVDs, even after adjustment for hypertension status, LVH,
SBP, and DBP (Table S1 and Figure 8C). Consequently, even
though the IVRT/ET and MPI both are independently associ-
ated with BP severity and LVMI, they provide independent and
incremental prognostic information to both BP and LVH. The
superiority of the IVRT/ET and the MPI to predict future ICVDs
may be because they detect miniscule impairment in the
myocardial function, regardless of whether the myocardium
has an ailing systolic or diastolic function.19 In the ailing
myocardium, the cardiac time intervals will change during
disease progression.41–44 As LV systolic function deteriorates,
the IVCT will be prolonged, because it takes longer for the
myocardial myocytes to achieve an LV pressure equal to that
of the aorta.44 Further, the ability of myocardial myocytes to
maintain a high LV pressure decreases, resulting in reduction
in the ET.44 As LV diastolic function becomes impaired, early
diastolic relaxation proceeds more slowly, explaining the
prolongation of the IVRT. Consequently, the IVRT/ET and the
MPI, deﬁned as [(IVCT+IVRT)/ET], will detect cardiac dys-
function with an increase, regardless of whether the LV has
impaired systolic or diastolic function.45,46 Therefore, in the
general population, the IVRT/ET and MPI identiﬁes subtle
impairments in the cardiac function (both systolic and
diastolic) that may be unnoticed with conventional echocar-
diography13,14(Figure 3) and can improve risk stratiﬁcation
strategies evaluating future risk of fulminant hypertension-
related ICVDs incremental to the traditional predictors. In
accordance with this, adding IVRT/ET or MPI to the clinical
predictors from the Framingham Risk Score,32 the SCORE risk
chart,34 and the ESH/ESC risk chart1 yielded better predicting
models with signiﬁcant increases in the categorical net
reclassiﬁcation improvements. However, we found that
hypertension signiﬁcantly modiﬁed the relationship between
all the cardiac time intervals containing information about
diastolic function (IVRT, IVRT/ET, and MPI) and the risk of
future ICVDs. These cardiac time intervals primarily predicted
hypertension-related ICVDs in participants with hypertension
but not in participants without hypertension (Figure 8D).
Similarly, a previous study demonstrated that the presence of
diastolic dysfunction, determined by a short deceleration
time, predicted all-cause mortality only in hypertensive heart
failure patients and not in heart failure patients without
hypertension.47 Therefore, in participants with hypertension,
who are in particularly high risk of future ICVDs,3 the IVRT/ET
and MPI may be useful cardiac measures for risk stratiﬁca-
tion. They are simple to obtain, have high reproducibil-
ity,19,21,22 and encompass information on BP severity, LV
geometry, and risk of future ICVDs.
Limitations
The inhabitants of Denmark and the study population are
primarily white, which limits the generalizability of our ﬁndings
to other general populations with other race/ethnicity
compositions.
Participants with short-lived or prolonged periods of
hypertension were treated similarly in the analyses. It would
be relevant to know who were well controlled during the
follow-up period because this might have inﬂuenced the
incidence of ICVDs. Unfortunately, this information was not
collected. We, however, adjust for the SBP and DBP at
baseline in our multivariable models, and uncontrolled
hypertension at baseline is therefore taken into account in
the present report.
Conclusion
The cardiac time intervals (especially the IVRT, IVRT/ET, and
MPI) displayed a signiﬁcant dose–response relationship, with
increasing severity of elevated BP and increasing LVMI.
Further, they identiﬁed impaired cardiac function in partici-
pants with hypertension, not only independent of conven-
tional risk factors but also in participants with a normal
conventional echocardiographic examination. Additionally, in
the general population, the IVRT/ET and MPI are powerful and
independent predictors of future hypertension-related ICVDs,
especially in participants with known hypertension. They
provide prognostic information incremental to clinical vari-
ables from the Framingham Risk Score, the SCORE risk chart,
and the ESH/ESC risk chart.
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SUPPLEMENTAL MATERIAL 
 
Supplemental Table S1. Unadjusted and adjusted a competing risk Cox proportional hazards regression models depicting the cardiac time 
intervals as predictors of future ischemic cardiovascular disease (ICVD)(number of events = 435) 
 Univariable 
 
 
SHR (95% CI) 
 
 
 
P-value 
Adjusted for Age, 
gender, systolic 
and diastolic BP  
SHR (95% CI) 
 
 
 
P-value 
Multivariable 
Adjustment  
 
SHR (95% CI) 
 
 
 
P-value 
Multivariable 
Adjustment 
in hypertensive  
SHR (95% CI) 
 
 
 
P-value 
IVRT per 10 ms 
increase 
1.19 (1.15-1.23) <0.001 1.04 (0.99-1.09) 0.10 1.04 (0.99-1.10) 0.09 1.04 (0.99-1.10) 0.12 
IVCT per 10 ms 
increase 
1.15 (1.08-1.23) <0.001 1.09 (1.02-1.17) 0.018 1.07 (0.98-1.16) 0.14   
ET per 10 ms 
decrease 
1.07 (1.03-1.11) <0.001 1.03 (0.99-1.07) 0.12 1.02 (0.96-1.08) 0.62   
IVRT/ET per 0.1 
increase 
1.39 (1.28-1.51) <0.001 1.13 (1.03-1.24) 0.007 1.11 (1.00-1.23) 0.050 1.09 (0.99-1.22) 0.09 
IVCT/ET per 0.1 
increase 
1.54 (1.31-1.81) <0.001 1.33 (1.10-1.61) 0.003 1.20 (0.96-1.50) 0.11   
MPI per 0.1 
increase 
1.35 (1.28-1.42) <0.001 1.14 (1.05-1.24) 0.001 1.11 (1.01-1.21) 0.024 1.12 (1.01-1.23) 0.027 
Multivariable adjustment indicates adjustment for age, gender, BMI, eGFR, heart rate, hypertension, systolic blood pressure, diastolic 
blood pressure, diabetes, cholesterol, smoking status, atrial fibrillation, IHD, previous ischemic stroke, LVEF<50%, diastolic dysfunction 
and LV hypertroph 
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